Inventor · disambiguated record
Gad S. Cojocaru
Also filed as: COJOCARU GAD S · COJOCARU Gad
25 granted patents·33 pending applications·269 citations·filing 2005–2025
96Inventor score
Top patents by PatentIndex Score
58 records- 0197US7569662B2Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of lung cancerCOMPUGEN LTD·Filed 2005·Granted Aug 4, 2009·73 cites·3 claims
- 0296US7667001B1Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of lung cancerCOMPUGEN LTD·Filed 2007·Granted Feb 23, 2010·75 cites·9 claims
- 0395US12312404B2Anti-PVRIG antibodies and methods of useCOMPUGEN LTD·Filed 2023·Granted May 27, 2025·1 cites·16 claims
- 0494US11623955B2Anti-PVRIG antibodies and methods of useCOMPUGEN LTD·Filed 2020·Granted Apr 11, 2023·3 cites·33 claims
- 0594US9714289B2Anti-PVRIG antibodies and methods of useCOMPUGEN LTD·Filed 2016·Granted Jul 25, 2017·14 cites·20 claims
- 0693US10124061B2Anti-TIGIT antibodies, anti-PVRIG antibodies and combinations thereofCOMPUGEN LTD·Filed 2017·Granted Nov 13, 2018·9 cites·20 claims
- 0793US7332569B2Brain natriuretic peptide spliced variantCOMPUGEN LTD·Filed 2005·Granted Feb 19, 2008·26 cites·1 claims
- 0892US10751415B2Anti-TIGIT antibodies, anti-PVRIG antibodies and combinations thereofCOMPUGEN LTD·Filed 2017·Granted Aug 25, 2020·6 cites·22 claims
- 0992US10213505B2Anti-TIGIT anibodies, anti-PVRIG antibodies and combinations thereofCOMPUGEN LTD·Filed 2018·Granted Feb 26, 2019·6 cites·2 claims
- 1091US11220542B2Anti-PVRIG antibodies and methods of useCOMPUGEN LTD·Filed 2016·Granted Jan 11, 2022·3 cites·42 claims
- 1190US10227408B2Anti-PVRIG antibodies and methods of useCOMPUGEN LTD·Filed 2016·Granted Mar 12, 2019·6 cites·20 claims
- 1290US7345142B2Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of cardiac diseaseCOMPUGEN LTD·Filed 2005·Granted Mar 18, 2008·16 cites·8 claims
- 1387US7842459B2Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosisCOMPUGEN LTD·Filed 2005·Granted Nov 30, 2010·7 cites·5 claims
- 1486US7939634B2Polynucleotides encoding polypeptides and methods using sameCOMPUGEN LTD·Filed 2005·Granted May 10, 2011·9 cites·5 claims
- 1586US7714100B2Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of cardiac diseaseCOMPUGEN LTD·Filed 2007·Granted May 11, 2010·3 cites·6 claims
- 1684US2025333503A1Anti-pvrig antibodies and methods of useCOMPUGEN LTD·Filed 2025·Application pending·0 cites
- 1783US11701424B2Anti-TIGIT antibodies, anti-PVRIG antibodies and combinations thereofCOMPUGEN LTD·Filed 2020·Granted Jul 18, 2023·1 cites·30 claims
- 1882US7553948B2Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of ovarian cancerCOMPUGEN LTD·Filed 2007·Granted Jun 30, 2009·6 cites·5 claims
- 1981US2024025973A1Pvrig polypeptides and methods of treatmentCOMPUGEN LTD·Filed 2023·Application pending·0 cites
- 2079US2024139318A1Anti-tigit antibodies, anti-pvrig antibodies and combinations thereofCOMPUGEN LTD·Filed 2023·Application pending·0 cites
- 2178US10550173B2PVRIG polypeptides and methods of treatmentCOMPUGEN LTD·Filed 2016·Granted Feb 4, 2020·2 cites·10 claims
- 2275US11795220B2Anti-PVRIG antibodies and methods of useCOMPUGEN LTD·Filed 2020·Granted Oct 24, 2023·0 cites·24 claims
- 2372US2024287174A1Hide1 compositions and methodsCOMPUGEN LTD·Filed 2023·Application pending·0 cites
- 2470US11795209B2PVRIG polypeptides and methods of treatmentCOMPUGEN LTD·Filed 2020·Granted Oct 24, 2023·0 cites·15 claims
- 2570US7906635B2Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of ovarian cancerCOMPUGEN LTD·Filed 2009·Granted Mar 15, 2011·2 cites·8 claims
- 2670US2010248270A1Novel Nucleotide and Amino Acid Sequences, and Assays and Methods of Use Thereof for Diagnosis of Cardiac DiseaseCOMPUGEN LTD·Filed 2009·Application pending·0 cites
- 2768US10351625B2Anti-PVRIG antibodies and methods of useCOMPUGEN LTD·Filed 2018·Granted Jul 16, 2019·0 cites·34 claims
- 2865US2024425607A1Il-18bp antagonist antibodies and their use in monotherapy and combination therapy in the treatment of cancerCOMPUGEN LTD·Filed 2024·Application pending·0 cites
- 2963US2025297018A1Il-18bp antagonist antibodies and their use in monotherapy and combination therapy in the treatment of cancerCOMPUGEN LTD·Filed 2023·Application pending·0 cites
- 3062US8999335B2Compositions and methods for treatment of drug resistant multiple myelomaCOJOCARU GAD S·Filed 2011·Granted Apr 7, 2015·1 cites·11 claims
- 3160US2024103010A1Pvrl2 and/or pvrig as biomarkers for treatmentCOMPUGEN LTD·Filed 2023·Application pending·0 cites
- 3258US2010068736A1Novel Nucleotide and Amino Acid Sequences, and Assays and Methods of Use Thereof for Diagnosis of Lung CancerCOMPUGEN LTD·Filed 2009·Application pending·0 cites
- 3357US2024082397A1Anti-pvrig antibodies formulations and uses thereofCOMPUGEN LTD·Filed 2022·Application pending·0 cites
- 3457US2025382364A1Anti-tigit and anti-pvrig in monotherapy and combination treatmentsCOMPUGEN LTD·Filed 2022·Application pending·0 cites
- 3556US2011091454A1Methods and systems for annotating biomolecular sequencesDIBER ALEX·Filed 2010·Application pending·0 cites
- 3656US2016068606A1Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsCOMPUGEN LTD·Filed 2015·Application pending·0 cites
- 3755US9347952B2Soluble VEGFR-1 variants for diagnosis of preeclampsiaCOMPUGEN LTD·Filed 2015·Granted May 24, 2016·0 cites·2 claims
- 3855US2017107284A1Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsCOMPUGEN LTD·Filed 2016·Application pending·0 cites
- 3955US2006068405A1Methods and systems for annotating biomolecular sequencesDIBER ALEX·Filed 2005·Application pending·0 cites
- 4054US2016216281A1Soluble vegfr-1 variants and assays and methods of use thereof for diagnosisCOMPUGEN LTD·Filed 2016·Application pending·0 cites
- 4154US2016272707A1Vstm5 antibodies, and uses thereof for treatment of cancer, infectious diseases and immune related diseasesCOMPUGEN LTD·Filed 2014·Application pending·0 cites
- 4254US2024076373A1Combination therapy with anti-pvrig antibodies formulations and anti-pd-1 antibodiesCOMPUGEN LTD·Filed 2022·Application pending·0 cites
- 4354US2023400467A1Pvrl2 and/or pvrig as biomarkers for treatmentCOMPUGEN LTD·Filed 2021·Application pending·0 cites
- 4452US2016177395A1Biomarkers for the prediction of renal injuryCOMPUGEN LTD·Filed 2016·Application pending·0 cites
- 4550US2007219125A1Novel thrombospondin-1 polynucleotides encoding variant thrombospondin-1 polypeptides and methods using sameCOJOCARU GAD S·Filed 2007·Application pending·0 cites
- 4649US2006147946A1Novel calcium channel variants and methods of use thereofAKIVA PINCHAS·Filed 2005·Application pending·0 cites
- 4748US2018305451A1Hide1 compositions and methodsCOMPUGEN LTD·Filed 2016·Application pending·0 cites
- 4848US2009215046A1Novel nucleotide and amino acid sequences, and assays methods of use thereof for diagnosis of colon cancerCOMPUGEN LTD·Filed 2007·Application pending·0 cites
- 4947US2009176217A1Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosisSELLA-TAVOR OSNAT·Filed 2006·Application pending·0 cites
- 5045US2015299333A1Compositions and methods for treatment of drug resistant multiple myelomaCOJOCARU GAD S·Filed 2015·Application pending·0 cites
Showing the top 50 of 58 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Gad S. Cojocaru files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →